Follow-up study on intensification therapy in the type 2 diabetes patients

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-10001264

Enrollment

Unknown

Registered

2010-09-27

Start date

2010-08-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Group A:human insulin, Insulin analogues

Group B:GLP-1 analogues

Group C:DPP-IV inhibitor

Total:human insulin, Insulin analogues, GLP-1 analogues, DPP-IV inhibitor

Eligibility

Sex/Gender

All

Age

14 Years to 70 Years

Inclusion criteria

Inclusion criteria: Type 2 diabetes patients without severe heart, brain, kidney diseases or congenital diseases.

Exclusion criteria

Exclusion criteria: Type 2 diabetes patients with severe heart, brain, kidney diseases or congenital diseases.

Design outcomes

Primary

Measure	Time frame
plasma insulin, C peptid;	—

Secondary

Measure	Time frame
plasma glucose, body weight;	—

Countries

China

Contacts

Public ContactKai Jiao

tdjkai@fmmu.edu.cn+86 029 84777042

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026